CIBC Asset Management Inc

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1021926 Toronto, A6

Position in ARWR

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$353,019

+$106,608 QoQ

Shares Held

4,331

+10.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#329

of 497 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CIBC Asset Management Inc holds $114,884,709 across 45 Biotechnology names. ARWR ranks #17 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	104,292	$51,804,965
2	REGN	Regeneron Pharmaceuticals, Inc.	41,660	$25,976,676
3	ALNY	Alnylam Pharmaceuticals, Inc.	29,342	$8,832,822
4	INCY	Incyte Corp	63,141	$7,157,663
5	MRNA	Moderna, Inc.	78,815	$5,519,414
6	TECH	BIO-TECHNE Corp	34,505	$2,437,778
7	RPRX	Royalty Pharma plc	34,087	$1,911,258
8	RVMD	Revolution Medicines, Inc.	8,768	$1,642,071

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$353,019	4,331	+10.2%	Shares	Sole	2026-08-03
2026-03-31	$246,411	3,930	0.0%	Shares	Sole	2026-05-12
2025-12-31	$260,912	3,930	-57.3%	Shares	Sole	2026-02-10
2025-09-30	$317,445	9,204	+108.4%	Shares	Sole	2025-10-31
2022-03-31	$203,137	4,417	0.0%	Shares	Sole	2022-05-06
2021-12-31	$292,847	4,417	+5.4%	Shares	Sole	2022-02-08
2021-09-30	$261,644	4,191	+10.0%	Shares	Sole	2021-11-09
2021-06-30	$315,461	3,809	0.0%	Shares	Sole	2021-08-16
2021-03-31	$252,574	3,809	+5.0%	Shares	Sole	2021-05-14
2020-12-31	$278,376	3,628	—	Shares	Sole	2021-02-03
No filing history on record for this holder in this stock.